论文信息 - CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide - 字舞流文

CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide

Ki Duk Park | M. Khanna | R. Khanna | F. Porreca | Chaoling Qu | Jennifer Xie | Kerry B Gilbraith | Lindsey A. Chew | Song Cai | A. Moutal | Shizhen Luo | M. Ibrahim | Xiaofang Yang | L. François-Moutal | Seul Ki Yeon | Wennan Li | S. Bellampalli | Aubin Moutal | Kerry B. Gilbraith